Latest Articles

Publication Date
PRM Welcomes Dr. Amro Elfeky to Enhance Endometriosis Care in Houston and Dallas - The Manila Times

PRM Welcomes Dr. Amro Elfeky to Enhance Endometriosis Care in Houston and Dallas The Manila Times

Published: June 10, 2025, 1:47 p.m.
Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer - The Malaysian Reserve

Neurocrine Biosciences Appoints Lewis Choi as Chief Information Officer The Malaysian Reserve

Published: June 10, 2025, 12:44 a.m.
The Findings of Color Doppler Ultrasound in AGA Fetuses in the Third Trimester with a Drop of Two Standard Deviations of Estimated Fetal Weight in Pregnant Women.

Detection of fetal growth restriction (FGR) in appropriate for gestational age (AGA) fetuses has not been comprehensively assessed. This study aim was to evaluate the findings of Doppler ultrasound in …

Published: June 10, 2025, midnight
ASCO 2025: Key Highlights in Endometrial and Related Cancers - Medscape

ASCO 2025: Key Highlights in Endometrial and Related Cancers Medscape

Published: June 9, 2025, 9:21 p.m.
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as Fir - GuruFocus

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as Fir GuruFocus

Published: June 9, 2025, 7:13 p.m.
High-flying doctor to LA stars Khloe Kardashian and Hailey Bieber reveals her new calling in life - Daily Mail

High-flying doctor to LA stars Khloe Kardashian and Hailey Bieber reveals her new calling in life Daily Mail

Published: June 9, 2025, 5:07 p.m.
Leveraging epigenetic aberrations in the pathogenesis of endometriosis: From DNA methylation to non-coding RNAs - Frontiers

Leveraging epigenetic aberrations in the pathogenesis of endometriosis: From DNA methylation to non-coding RNAs Frontiers

Published: June 9, 2025, 4:59 p.m.
Bindi Irwin Shared the First Thing Daughter Grace Did When She Got Home From Disneyland & It’s Classic Irwin - SheKnows

Bindi Irwin Shared the First Thing Daughter Grace Did When She Got Home From Disneyland & It’s Classic Irwin SheKnows

Published: June 9, 2025, 2:21 p.m.
AZN Initiates Phase 3 Trial for Enhertu in Advanced Endometrial Cancer | AZN Stock News - GuruFocus

AZN Initiates Phase 3 Trial for Enhertu in Advanced Endometrial Cancer | AZN Stock News GuruFocus

Published: June 9, 2025, 12:46 p.m.
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer - BioSpace

DESTINY-Endometrial01 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Expressing Primary Advanced or Recurrent Endometrial Cancer BioSpace

Published: June 9, 2025, 12:43 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!